700 A phase II trial of MOnaliZumab plus durvAlumab plus platinum-based chemotheRapy for first-line treatment of extensive stage small cell lung cancer (MOZART): A Hoosier Cancer Research Network study
Main Authors: | Seongho Kim, Jie Chi, Hirva Mamdani, Shadia I Jalal, Kristen Pizana, Qura Abid |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors
by: Jarushka Naidoo, et al.
Published: (2024-02-01) -
Understanding St. Louis’ Love for Hoosier
by: Daniel Duncan
Published: (2018-01-01) -
A converse to the jordan curve theorem for digital durves/
by: Rosenfeld, Azriel -
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
by: Thura, Min, et al.
Published: (2019) -
Mozart /
by: 295331 Wenborn, Neil
Published: (c199)